Campus events
Sustainability
Belforte del Chienti, March 3, 2022 – Simonelli Group supports and endorses the new Ancona branch of the NeMO (Neuro Muscular Onmicenter) Clinical Center, a facility inaugurated this morning at Torrette Hospital in the Marche capital. It is a highly specialized center designed to specifically address the needs of those with neuromuscular diseases (e.g. ALS, SMA, etc.) and muscular dystrophies. The main aim is to improve the quality of life of the people taken into care by providing them and their families with clinical, care and psychological support that meets their global needs.
“Research, business and territory are among the most valuable assets Simonelli Group invests in, aware that the territory is that area in which to create and spread well-being and growth,” – said Maurizio Giuli Executive for Corporate Strategy in Simonelli Group. “Also for this reason we have decided to give our support to the NeMO Clinical Center that invests in research, collaborates with universities in order to improve the quality of life of people affected by this type of diseases.”
For Simonelli Group, supporting the NeMO Center is a concrete way to provide support to the community in the Marche region and identify innovative solutions for the well-being of those facing this type of disease.
Pictured starting from left: Maurizio Giuli (Executive for Corporate Strategy, Simonelli Group), Alberto Fontana (President NEMo Clinical Center) and Manuela Feliziani (Sustainability Advisor, Simonelli Group).
“We are particularly happy to contribute to this important project because of its uniqueness in providing concrete answers to the multiple needs of patients suffering from neuromuscular diseases, offering them an innovative, competent and appropriate approach,” specified Manuela Feliziani, Sustainability Advisor Simonelli Group. “We share the social value of this initiative and particularly appreciate the character of Research,Integration and above allListening, values that we share and adopt every day in the different internal and external activities of Simonelli Group.” The innovative character of the project, in fact, matches the great attention of Simonelli Group in investing in research and technologies aimed at improving the result in the cup and raising the quality standards of coffee all over the world.
The NeMO Clinical Center network, active throughout Italy, cares for people with neuromuscular diseases, such as ALS, SMA, and Muscular Dystrophies, and today is a point of reference for diagnosis, treatment, and care on these diseases. At NeMO, everything revolves around the person, thanks to a targeted multidisciplinary care model that integrates multiprofessional and interdisciplinary skills to offer comprehensive care without discontinuity, implementing highly specialized rehabilitation programs targeted to the needs of each patient.
Being sustainable requires courage, but also an awareness of the return on value that is distributed in terms of territorial growth, well-being and quality of life. For the NEMO Clinical Center, capillary development in the territory is essential to be close to the need for care of those who experience such complex and disabling diseases, making it possible to ensure that an increasing number of people have access to innovative treatments.
“The culture of innovation, environmental protection and sustainability have been part of the company’s ‘DNA’ for many years now”-explains Nando Ottavi, Simonelli Group President. “Ours is a company devoted to the long term, growth and innovation; this is why Simonelli Group’s development cannot disregard the growth and welfare of the territory in which it operates and in which it has remained even in times when relocation might have seemed the most convenient choice. Supporting associations that invest in innovative solutions to improve the quality of life of people with different pathologies is certainly a choice that contributes to creating added value for our territory.”
